Clinical Trials Directory

Trials / Completed

CompletedNCT03521414

Glasgow Coma Scales and General Anesthesia

The Effect of Glasgow Coma Scales on General Anesthesia in Neurosurgery Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Trakya University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study evaluates the general anesthesia management with BIS monitorization in terms of hemodynamic stability, drug concentrations and drug consumption in patients who underwent surgery due to intracranial pathology and who were divided in three different GCS groups.

Detailed description

BIS monitoring is mostly used for anesthesia depth and sedation level follow-up, however it can also be used for monitoring consciousness after resuscitation of cases with acute brain injury and cardiac arrest. It is not always possible to monitor and objectively measure the changes in the level of consciousness in clinical practice. Therefore, device-based methods have been introduced in monitoring the state of consciousness. Bispectral index (BIS) monitoring may be preferred in follow up of the state of consciousness in critical patients such as those with acute brain injury, in terms of ease of use, ability to obtain numerical results and continuous monitoring. BIS monitoring is mostly used for follow up of anesthesia depth and sedation level, while it can also be applied for monitoring state of consciousness following resuscitation in cases with acute brain injury and cardiac arrest.In this study, we aimed to investigate general anesthesia management performed by bispectral index monitoring in patients who underwent surgery due to intracranial pathology and with different Glasgow Coma Scales.

Conditions

Interventions

TypeNameDescription
DEVICEBispectral index (BIS) monitoringWhen the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug
DRUGSevofluranewe used sevoflurane drug at inoperative

Timeline

Start date
2013-07-03
Primary completion
2015-02-01
Completion
2015-11-05
First posted
2018-05-11
Last updated
2018-05-11

Source: ClinicalTrials.gov record NCT03521414. Inclusion in this directory is not an endorsement.